Citations (107)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Dominika Lisiecka, Aine Kearns, Fiona Bourke, Ian Lawson & Cath Muir. (2022) A qualitative meta-synthesis of evidence (meta-ethnography) exploring the personal experiences of gastrostomy tube in neurodegenerative diseases: a case of motor neurone disease. Disability and Rehabilitation 44:18, pages 4949-4965.
Read now
Read now
Kinjal Thakor, Shelly Naud, Diantha Howard, Rup Tandan & Waqar Waheed. (2021) Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 360-367.
Read now
Read now
Dominika Lisiecka, Helen Kelly & Jeanne Jackson. (2021) How do people with Motor Neurone Disease experience dysphagia? A qualitative investigation of personal experiences. Disability and Rehabilitation 43:4, pages 479-488.
Read now
Read now
Kjetil Bjornevik, Éilis J. O’Reilly, Marianna Cortese, Jeremy D. Furtado, Laurence N. Kolonel, Loic Le Marchand, Marjorie L. Mccullough, Sabrina Paganoni, Michael A. Schwarzschild, Aladdin H. Shadyab, Joann E. Manson & Alberto Ascherio. (2021) Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 133-143.
Read now
Read now
Lise Sproson, Vitaveska Lanfranchi, Alexis Collins, Suresh K. Chhetri, Niamh Daly, Michelle Ennis, Lucie Glennon, George Gorrie, Emily Jay, Rachael Marsden, Avril D. McCarthy, Liz Pryde, Rhys Roberts, Anna Rutherford, Jessica Ryan, Gill Stot, Wendy B. Tindale, Pamela J. Shaw & Christopher J. McDermott. (2021) Fit for purpose? A cross-sectional study to evaluate the acceptability and usability of HeadUp, a novel neck support collar for neurological neck weakness. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 38-45.
Read now
Read now
Boeun Kim, Youri Jin, Seung Hyun Kim & Yongsoon Park. (2020) Association between macronutrient intake and amyotrophic lateral sclerosis prognosis. Nutritional Neuroscience 23:1, pages 8-15.
Read now
Read now
Shyuan T. Ngo, Ruben P.A. van Eijk, V. Chachay, Leonard H. van den Berg, Pamela A. McCombe, Robert D. Henderson & Frederik J. Steyn. (2019) Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 497-505.
Read now
Read now
Shyuan T Ngo, Jia D Mi, Robert D Henderson, Pamela A McCombe & Frederik J Steyn. (2017) Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degenerative Neurological and Neuromuscular Disease 7, pages 95-108.
Read now
Read now
Antonio Fasano, Nicola Fini, Diana Ferraro, Laura Ferri, Marco Vinceti & Jessica Mandrioli. (2017) Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 233-242.
Read now
Read now
Caitlin S. Jackson-Tarlton, Timothy J. Benstead & Steve Doucette. (2016) Correlating factors in the recommendation of feeding tubes in the nutritional management of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:7-8, pages 515-521.
Read now
Read now
Caroline Ingre, Per M Roos, Fredrik Piehl, Freya Kamel & Fang Fang. (2015) Risk factors for amyotrophic lateral sclerosis. Clinical Epidemiology 7, pages 181-193.
Read now
Read now
Muhammad K. Rafiq, Ellen Lee, Michael Bradburn, Christopher J. McDermott & Pamela J. Shaw. (2015) Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 478-484.
Read now
Read now
. (2013) THEME 9 IN VIVO EXPERIMENTAL MODELS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup2, pages 177-199.
Read now
Read now
Ronit Reich-Slotky, Jinsy Andrews, Bin Cheng, Richard Buchsbaum, Diane Levy, Petra Kaufmann & John L. P. Thompson. (2013) Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:3, pages 212-216.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Articles from other publishers (92)
Ramona Meanti, Elena Bresciani, Laura Rizzi, Silvia Coco, Vanessa Zambelli, Anna Dimitroulas, Laura Molteni, Robert J. Omeljaniuk, Vittorio Locatelli & Antonio Torsello. (2023) Potential Applications for Growth Hormone Secretagogues Treatment of
Amyotrophic Lateral Sclerosis. Current Neuropharmacology 21:12, pages 2376-2394.
Crossref
Crossref
Kelly G. Gwathmey, Philippe Corcia, Chris J. McDermott, Angela Genge, Stefan Sennfält, Mamede de Carvalho & Caroline Ingre. (2023) Diagnostic delay in amyotrophic lateral sclerosis. European Journal of Neurology 30:9, pages 2595-2601.
Crossref
Crossref
Katarina Maksimovic, Mohieldin Youssef, Justin You, Hoon-Ki Sung & Jeehye Park. (2023) Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models. Biomolecules 13:5, pages 863.
Crossref
Crossref
Christopher Q. Rogers, Melissa Ramirez, Carol S. Landon, Janine M. DeBlasi, Andrew P. Koutnik, Csilla Ari & Dominic P. D’Agostino. (2023) A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS. Nutrients 15:8, pages 1821.
Crossref
Crossref
Maruša Barbo & Metka Ravnik-Glavač. (2023) Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes 14:2, pages 325.
Crossref
Crossref
Tatsuki Sugisawa, Harumi Morioka, Takehisa Hirayama, Osamu Kano & Satoru Ebihara. (2023) Multidisciplinary clinic contributes to the decreasing trend in the number of emergency hospitalizations for amyotrophic lateral sclerosis in Japan. Journal of Clinical Neuroscience 107, pages 133-137.
Crossref
Crossref
Christen Shoesmith. 2023. Neuropalliative Care, Part II. Neuropalliative Care, Part II
139
155
.
Kaitlyn H. Hajdarovic, Doudou Yu & Ashley E. Webb. (2022) Understanding the aging hypothalamus, one cell at a time. Trends in Neurosciences 45:12, pages 942-954.
Crossref
Crossref
Helena Chaytow, Emily Carroll, David Gordon, Yu-Ting Huang, Dinja van der Hoorn, Hannah Louise Smith, Thomas Becker, Catherina Gwynne Becker, Kiterie Maud Edwige Faller, Kevin Talbot & Thomas Henry Gillingwater. (2022) Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis. eBioMedicine 83, pages 104202.
Crossref
Crossref
Leanne Jiang & Shyuan T. Ngo. (2022) Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis. Metabolites 12:8, pages 709.
Crossref
Crossref
Dominika Lisiecka, Áine Kearns & Aisling Bonass. (2022) A qualitative systematic review of family caregivers’ experiences of artificial nutrition and hydration at home: A meta‐ethnography. International Journal of Language & Communication Disorders 57:4, pages 717-736.
Crossref
Crossref
Jin‐Yue Li, Li‐Ying Cui, Xiao‐Han Sun, Dong‐chao Shen, Xun‐Zhe Yang, Qing Liu & Ming‐Sheng Liu. (2022) Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 9:7, pages 1027-1038.
Crossref
Crossref
Munira Essat, Elizabeth Coates, Mark Clowes, Daniel Beever, Gemma Hackney, Sean White, Theocharis Stavroulakis, Vanessa Halliday & Christopher McDermott. (2022) Understanding the current nutritional management for people with amyotrophic lateral sclerosis - A mapping review. Clinical Nutrition ESPEN 49, pages 328-340.
Crossref
Crossref
Swati Dhasmana, Anupam Dhasmana, Acharan S. Narula, Meena Jaggi, Murali M. Yallapu & Subhash C. Chauhan. (2022) The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sciences 288, pages 120156.
Crossref
Crossref
Jin-Hui Hor, Munirah Mohamad Santosa & Shi-Yan Ng. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
99
120
.
Tesfaye Wolde Tefera, Frederik J. Steyn, Shyuan T. Ngo & Karin Borges. (2021) CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?. Cell & Bioscience 11:1.
Crossref
Crossref
Sanaz Gabery, Rebekah M Ahmed, Jashelle Caga, Matthew C Kiernan, Glenda M Halliday & Åsa Petersén. (2021) Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology 47:7, pages 979-989.
Crossref
Crossref
Shyuan T. Ngo, Hao Wang, Robert D. Henderson, Cyril Bowers & Frederik J. Steyn. (2021) Ghrelin as a treatment for amyotrophic lateral sclerosis. Journal of Neuroendocrinology 33:7.
Crossref
Crossref
Payam Sarraf, Sama Bitarafan, Shahriar Nafissi, Davood Fathi, Faezeh Abaj, Zoya Asl Motallebnejad, Reza Teimouri & Kolsoom Vahedi. (2021) The correlation of the serum level of L-carnitine with disease severity in patients with Amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 89, pages 232-236.
Crossref
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Crossref
Laura Ferri, Paola Ajdinaj, Marianna Gabriella Rispoli, Claudia Carrarini, Filomena Barbone, Damiano D’Ardes, Margherita Capasso, Antonio Di Muzio, Francesco Cipollone, Marco Onofrj & Laura Bonanni. (2021) Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review. Biomolecules 11:6, pages 867.
Crossref
Crossref
Cyril Quessada, Alexandra Bouscary, Frédérique René, Cristiana Valle, Alberto Ferri, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells 10:6, pages 1449.
Crossref
Crossref
Mika Kurihara, Shigeki Bamba, Shoko Yasuhara, Akihiko Itoh, Taishi Nagao, Naoko Nakanishi, Ryutaro Nakamura, Nobuhiro Ogawa, Akihiro Kitamura, Isamu Yamakawa, Hyou Kim, Mitsuru Sanada, Makoto Urushitani & Masaya Sasaki. (2021) Factors Affecting Energy Metabolism and Prognosis in Patients with Amyotrophic Lateral Sclerosis. Annals of Nutrition and Metabolism 77:4, pages 236-243.
Crossref
Crossref
Rajka Maria Liscic, Antonella Alberici, Nigel John Cairns, Maurizio Romano & Emanuele Buratti. (2020) From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline. Molecular Neurodegeneration 15:1.
Crossref
Crossref
Lishun Xiao, Zhongshang Yuan, Siyi Jin, Ting Wang, Shuiping Huang & Ping Zeng. (2020) Multiple-Tissue Integrative Transcriptome-Wide Association Studies Discovered New Genes Associated With Amyotrophic Lateral Sclerosis. Frontiers in Genetics 11.
Crossref
Crossref
Pilar Rojas, Ana I. Ramírez, José A. Fernández-Albarral, Inés López-Cuenca, Elena Salobrar-García, Manuel Cadena, Lorena Elvira-Hurtado, Juan J. Salazar, Rosa de Hoz & José M. Ramírez. (2020) Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement. Frontiers in Neuroscience 14.
Crossref
Crossref
Dominika Lisiecka, Helen Kelly & Jeanne Jackson. (2020) ‘This is your golden time. You enjoy it and you’ve plenty time for crying after’: How dysphagia impacts family caregivers of people with amyotrophic lateral sclerosis – A qualitative study. Palliative Medicine 34:8, pages 1097-1107.
Crossref
Crossref
Mark R Janse van Mantgem, Ruben P A van Eijk, Hannelore K van der Burgh, Harold H G Tan, Henk-Jan Westeneng, Michael A van Es, Jan H Veldink & Leonard H van den Berg. (2020) Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 91:8, pages 867-875.
Crossref
Crossref
Kristin Diekmann, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho, Hilmi Uysal, Alma Osmanovic, Olivia Schreiber-Katz, Susanne Petri & Sonja Körner. (2020) Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. Journal of Neurology 267:7, pages 2130-2141.
Crossref
Crossref
Mara-Luciana Floare & Scott P. Allen. (2020) Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis. Neuroscience Insights 15, pages 263310552095730.
Crossref
Crossref
Christine Germeys, Tijs Vandoorne, Valérie Bercier & Ludo Van Den Bosch. (2019) Existing and Emerging Metabolomic Tools for ALS Research. Genes 10:12, pages 1011.
Crossref
Crossref
Jin-Sung Park, Young Woo Do, Jin-Mo Park, Hung Youl Seok & Donghwi Park. (2019) Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study. Neurological Sciences 40:12, pages 2509-2514.
Crossref
Crossref
Kenichiro Sato, Atsushi Iwata, Masanori Kurihara, Yu Nagashima, Tatsuo Mano & Tatsushi Toda. (2019) Estimating acceleration time point of respiratory decline in ALS patients: A novel metric. Journal of the Neurological Sciences 403, pages 7-12.
Crossref
Crossref
Qi‐Jie Zhang, Yang Chen, Xiao‐Huan Zou, Wei Hu, Xue‐Liang Lin, Shang‐Yuan Feng, Fa Chen, Liu‐Qing Xu, Wan‐Jin Chen & Ning Wang. (2019) Prognostic analysis of amyotrophic lateral sclerosis based on clinical features and plasma surface‐enhanced Raman spectroscopy. Journal of Biophotonics 12:8.
Crossref
Crossref
Cristina Moglia, Andrea Calvo, Maurizio Grassano, Antonio Canosa, Umberto Manera, Fabrizio D'Ovidio, Alessandro Bombaci, Enrica Bersano, Letizia Mazzini, Gabriele Mora & Adriano Chiò. (2019) Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. Journal of Neurology, Neurosurgery & Psychiatry 90:6, pages 666-673.
Crossref
Crossref
Ping Zeng, Xinghao Yu & Haibo Xu. (2019) Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches. Frontiers in Neurology 10.
Crossref
Crossref
Leonard H. van den BergEric SorensonGary GronsethEric A. MacklinJinsy AndrewsRobert H. BalohMichael BenatarJames D. BerryAdriano Chio, Philippe CorciaAngela GengeAmelie K. GubitzCatherine Lomen-HoerthChristopher J. McDermottErik P. PioroJeffrey Rosenfeld, Vincenzo SilaniMartin R. TurnerMarkus WeberBenjamin Rix BrooksRobert G. MillerHiroshi Mitsumoto. (2019) Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 92:14.
Crossref
Crossref
Rangariroyashe Hannah Chipika, Eoin Finegan, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation
981
1033
.
Rup Tandan, Waqar Waheed & Connor Scagnelli. 2019. Handbook of Famine, Starvation, and Nutrient Deprivation. Handbook of Famine, Starvation, and Nutrient Deprivation
1
53
.
Mary Kay Floeter & Tania F. Gendron. (2018) Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72. Frontiers in Neurology 9.
Crossref
Crossref
Ali Jawaid, Romesa Khan, Magdalini Polymenidou & Paul E. Schulz. (2018) Disease-modifying effects of metabolic perturbations in ALS/FTLD. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Chun-Jiang Yu, Li Wang, Sen-Lin Mao, Ying Zhang, Ling-Ling Song, Ling-Yu Cai & Ye Tao. (2018) The clinical assessment of amyotrophic lateral sclerosis patients’ prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI). BMC Neurology 18:1.
Crossref
Crossref
Victoria L. Hodgkinson, Josh Lounsberry, Ario Mirian, Angela Genge, Timothy Benstead, Hannah Briemberg, Ian Grant, Walter Hader, Wendy S. Johnston, Sanjay Kalra, Gary Linassi, Rami Massie, Michel Melanson, Colleen O’Connell, Kerri Schellenberg, Christen Shoesmith, Sean Taylor, Scott Worley, Lorne Zinman & Lawrence Korngut. (2018) Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:6, pages 652-659.
Crossref
Crossref
Efthimios DardiotisVasileios SiokasMaria SokratousZisis TsourisAthina-Maria AloizouDesponia FlorouMetaxia DastamaniAlexios-Fotios A. MentisAlexandros G. Brotis. (2018) Body mass index and survival from amyotrophic lateral sclerosis. Neurology Clinical Practice 8:5, pages 437-444.
Crossref
Crossref
Tijs Vandoorne, Katrien De Bock & Ludo Van Den Bosch. (2018) Energy metabolism in ALS: an underappreciated opportunity?. Acta Neuropathologica 135:4, pages 489-509.
Crossref
Crossref
Pauline Vercruysse, Didier Vieau, David Blum, Åsa Petersén & Luc Dupuis. (2018) Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
F. D'Ovidio, A. d'Errico, P. Carnà, A. Calvo, G. Costa & A. Chiò. (2018) The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. European Journal of Neurology 25:1, pages 164-170.
Crossref
Crossref
Konstantinos Mitropoulos, Eleni Merkouri Papadima, Georgia Xiromerisiou, Angeliki Balasopoulou, Kyriaki Charalampidou, Vasiliki Galani, Krystallia-Vassiliki Zafeiri, Efthymios Dardiotis, Styliani Ralli, Georgia Deretzi, Anne John, Kyriaki Kydonopoulou, Elpida Papadopoulou, Alba di Pardo, Fulya Akcimen, Annalisa Loizedda, Valerija Dobričić, Ivana Novaković, Vladimir S. Kostić, Clint Mizzi, Brock A. Peters, Nazli Basak, Sandro Orrù, Evangelos Kiskinis, David N. Cooper, Spyridon Gerou, Radoje Drmanac, Marina Bartsakoulia, Evangelia-Eirini Tsermpini, Georgios M. Hadjigeorgiou, Bassam R. Ali, Theodora Katsila & George P. Patrinos. (2017) Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients. Human Genomics 11:1.
Crossref
Crossref
Raphael Simon Peter, Angela Rosenbohm, Luc Dupuis, Torben Brehme, Jan Kassubek, Dietrich Rothenbacher, Gabriele Nagel & Albert Christian Ludolph. (2017) Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. European Journal of Epidemiology 32:10, pages 901-908.
Crossref
Crossref
Rosa C. Paolicelli, Ali Jawaid, Christopher M. Henstridge, Andrea Valeri, Mario Merlini, John L. Robinson, Edward B. Lee, Jamie Rose, Stanley Appel, Virginia M.-Y. Lee, John Q. Trojanowski, Tara Spires-Jones, Paul E. Schulz & Lawrence Rajendran. (2017) TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron 95:2, pages 297-308.e6.
Crossref
Crossref
Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, Wolfgang Koenig, Luc Dupuis, Dietrich Rothenbacher & Albert C. Ludolph. (2017) Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany. Scientific Reports 7:1.
Crossref
Crossref
Yu-Ju Liu, Po-Yi Tsai & Yijuang Chern. (2017) Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Matthew D. Cykowski, Suzanne Z. Powell, Leif E. Peterson, Joan W. Appel, Andreana L. Rivera, Hidehiro Takei, Ellen Chang & Stanley H. Appel. (2017) Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. Journal of Neuropathology & Experimental Neurology 76:5, pages 402-413.
Crossref
Crossref
Rebekah M. Ahmed, Muireann Irish, Janet van Eersel, Arne Ittner, Yazi D. Ke, Alexander Volkerling, Julia van der Hoven, Kimi Tanaka, Tim Karl, Michael Kassiou, Jillian J. Kril, Olivier Piguet, Jürgen Götz, Matthew C. Kiernan, Glenda M. Halliday, John R. Hodges & Lars M. Ittner. (2017) Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology. Neuroscience & Biobehavioral Reviews 74, pages 126-138.
Crossref
Crossref
Timothy Benstead, Caitlin Jackson-Tarlton & Desmond Leddin. (2016) Nutrition with Gastrostomy Feeding Tubes for Amyotrophic Lateral Sclerosis in Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43:6, pages 796-800.
Crossref
Crossref
Esther V. Hobson & Christopher J. McDermott. (2016) Supportive and symptomatic management of amyotrophic lateral sclerosis. Nature Reviews Neurology 12:9, pages 526-538.
Crossref
Crossref
R. M. Ahmed, J. Caga, E. Devenney, S. Hsieh, L. Bartley, E. Highton-Williamson, E. Ramsey, M. Zoing, G. M. Halliday, O. Piguet, J. R. Hodges & M. C. Kiernan. (2016) Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. Journal of Neurology 263:8, pages 1593-1603.
Crossref
Crossref
Nilo Riva, Federica Agosta, Christian Lunetta, Massimo Filippi & Angelo Quattrini. (2016) Recent advances in amyotrophic lateral sclerosis. Journal of Neurology 263:6, pages 1241-1254.
Crossref
Crossref
Leah Bryan, Wendy Kaye, Vinicius Antao, Paul Mehta, Oleg Muravov & D. Kevin Horton. (2016) Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data. PLOS ONE 11:4, pages e0153683.
Crossref
Crossref
Sabrina K. Hollinger, Ike S. Okosun & Cassie S. Mitchell. (2016) Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?. Frontiers in Neurology 7.
Crossref
Crossref
Nirma D. Perera & Bradley J. Turner. (2015) AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis. Neurochemical Research 41:3, pages 544-553.
Crossref
Crossref
Zara A. Ioannides, Shyuan T. Ngo, Robert D. Henderson, Pamela A. McCombe & Frederik J. Steyn. (2016) Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression. Neurodegenerative Diseases 16:5-6, pages 382-397.
Crossref
Crossref
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
869
903
.
A. Jawaid, J. A. Brown & P. E. Schulz. (2015) Diabetes mellitus in amyotrophic lateral sclerosis: Dr Jekyll or Mr Hyde?. European Journal of Neurology 22:11, pages 1419-1420.
Crossref
Crossref
Anne-Chantal Héritier, Jean-Paul Janssens, Dan Adler, Ruxandra Iancu Ferfoglia & Laurence Genton. (2015) Should patients with ALS gain weight during their follow-up?. Nutrition 31:11-12, pages 1368-1371.
Crossref
Crossref
Carlayne E. Jackson, April L. McVey, Stacy Rudnicki, Mazen M. Dimachkie & Richard J. Barohn. (2015) Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 889-908.
Crossref
Crossref
Alexandre Henriques, Hélène Blasco, Marie-Céline Fleury, Philippe Corcia, Andoni Echaniz-Laguna, Laura Robelin, Gabrielle Rudolf, Thiebault Lequeu, Martine Bergaentzle, Christian Gachet, Pierre-François Pradat, Eric Marchioni, Christian R. Andres, Christine Tranchant, Jose-Luis Gonzalez De Aguilar & Jean-Philippe Loeffler. (2015) Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis. PLOS ONE 10:7, pages e0131512.
Crossref
Crossref
Lavinia Palamiuc, Anna Schlagowski, Shyuan T Ngo, Aurelia Vernay, Sylvie Dirrig‐Grosch, Alexandre Henriques, Anne‐Laurence Boutillier, Joffrey Zoll, Andoni Echaniz‐Laguna, Jean‐Philippe Loeffler & Frédérique René. (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Molecular Medicine 7:5, pages 526-546.
Crossref
Crossref
Vincent Roubeau, Hélène Blasco, François Maillot, Philippe Corcia & Julien Praline. (2015) Nutritional assessment of amyotrophic lateral sclerosis in routine practice: Value of weighing and bioelectrical impedance analysis. Muscle & Nerve 51:4, pages 479-484.
Crossref
Crossref
Archi Joardar, Judith Menzl, Taylor C. Podolsky, Ernesto Manzo, Patricia S. Estes, Sarah Ashford & Daniela C. Zarnescu. (2015) PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43. Human Molecular Genetics 24:6, pages 1741-1754.
Crossref
Crossref
Rohini Raman, Scott P Allen, Emily F Goodall, Shelley Kramer, Lize-Linde Ponger, Paul R. Heath, Marta Milo, Hannah C. Hollinger, Theresa Walsh, J Robin Highley, Simon Olpin, Christopher J. McDermott, Pamela J. Shaw & Janine Kirby. (2015) Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathology and Applied Neurobiology 41:2, pages 201-226.
Crossref
Crossref
S.T. Ngo & F.J. Steyn. (2015) The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regeneration 4:1, pages 4:5.
Crossref
Crossref
Joachim Wolf, Anton Safer, Johannes C. Wöhrle, Frederick Palm, Wilfred A. Nix, Matthias Maschke & Armin J. Grau. (2015) Factors Predicting Survival in ALS Patients - Data from a Population-Based Registry in Rhineland-Palatinate, Germany. Neuroepidemiology 44:3, pages 149-155.
Crossref
Crossref
Yongjin Zhu, Anastasios Fotinos, Lilly L.J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. (2015) Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discovery Today 20:1, pages 65-75.
Crossref
Crossref
Matthew D Cykowski, Hidehiro Takei, Paul E Schulz, Stanley H Appel & Suzanne Z Powell. (2014) TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathologica Communications 2:1.
Crossref
Crossref
Alain Lekoubou, Tandi E Matsha, Eugene Sobngwi & Andre P Kengne. (2014) Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Research Notes 7:1.
Crossref
Crossref
Rebekah M. AhmedMia MacMillanLauren BartleyGlenda M. HallidayMatthew C. KiernanJohn R. HodgesOlivier Piguet. (2014) Systemic metabolism in frontotemporal dementia. Neurology 83:20, pages 1812-1818.
Crossref
Crossref
Maria A. Lim, Kendra K. Bence, Ishani Sandesara, Pénélope Andreux, Johan Auwerx, Jeff Ishibashi, Patrick Seale & Robert G. Kalb. (2014) Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. Human Molecular Genetics 23:18, pages 4995-5008.
Crossref
Crossref
R. M. Ahmed, E. Mioshi, J. Caga, M. Shibata, M. Zoing, L. Bartley, O. Piguet, J. R. Hodges & M. C. Kiernan. (2014) Body mass index delineates ALS from FTD: implications for metabolic health. Journal of Neurology 261:9, pages 1774-1780.
Crossref
Crossref
Ali Jawaid, Sabrina Paganoni, Cecile Hauser & Paul E. Schulz. (2014) Trials of Antidiabetic Drugs in Amyotrophic Lateral Sclerosis: Proceed with Caution?. Neurodegenerative Diseases 13:4, pages 205-208.
Crossref
Crossref
P. Clavelou, M. Blanquet, F. Peyrol, L. Ouchchane & L. Gerbaud. (2013) Rates of progression of weight and forced vital capacity as relevant measurement to adapt Amyotrophic Lateral Sclerosis management for patient Result of a French multicentre cohort survey. Journal of the Neurological Sciences 331:1-2, pages 126-131.
Crossref
Crossref
Eva Lindauer, Luc Dupuis, Hans-Peter Müller, Heiko Neumann, Albert C. Ludolph & Jan Kassubek. (2013) Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 8:6, pages e67783.
Crossref
Crossref
Teresa Holm, André Maier, Paul Wicks, Dirk Lang, Peter Linke, Christoph Münch, Laura Steinfurth, Robert Meyer & Thomas Meyer. (2013) Severe Loss of Appetite in Amyotrophic Lateral Sclerosis Patients: Online Self-Assessment Study. interactive Journal of Medical Research 2:1, pages e8.
Crossref
Crossref
Ali Jawaid, Henning Leske & Manuela Neumann. (2012) Body mass index is associated with biological CSF markers of core brain pathology in Alzheimer's disease. Neurobiology of Aging 33:7, pages e1-e2.
Crossref
Crossref
Lydia Coulter Kwee, Yutao Liu, Carol Haynes, Jason R. Gibson, Annjanette Stone, Steven A. Schichman, Freya Kamel, Lorene M. Nelson, Barbara Topol, Stephen K. Van Den Eeden, Caroline M. Tanner, Merit E. Cudkowicz, Daniela L. Grasso, Robert Lawson, Sumitra Muralidhar, Eugene Z. Oddone, Silke Schmidt & Michael A. Hauser. (2012) A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans. PLoS ONE 7:3, pages e32768.
Crossref
Crossref
Benoît Marin, Pierre Jésus, Pierre-Marie Preux, Philippe Couratier & Jean-Claude Desport. (2011) Troubles nutritionnels lors de la sclérose latérale amyotrophique (SLA). Nutrition Clinique et Métabolisme 25:4, pages 205-216.
Crossref
Crossref
L. Genton, V. Viatte, J.-P. Janssens, A.-C. Héritier & C. Pichard. (2011) Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clinical Nutrition 30:5, pages 553-559.
Crossref
Crossref
Sabrina Paganoni, Jing Deng, Matthew Jaffa, Merit E. Cudkowicz & Anne-Marie Wills. (2011) Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle & Nerve 44:1, pages 20-24.
Crossref
Crossref
J. Dorst, P. Kühnlein, C. Hendrich, J. Kassubek, A. D. Sperfeld & A. C. Ludolph. (2010) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. Journal of Neurology 258:4, pages 613-617.
Crossref
Crossref
Luc Dupuis, Pierre-François Pradat, Albert C Ludolph & Jean-Philippe Loeffler. (2011) Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology 10:1, pages 75-82.
Crossref
Crossref